Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lymphoma 25Leukemia 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Large B-Cell, Diffuse 16Lymphoma, Follicular 16Breast Neoplasms 16Leukemia, Myeloid, Acute 15Lymphoma, Non-Hodgkin 14Lymphoma, Mantle-Cell 13Lymphoma, Large-Cell, Immunoblastic 13Burkitt Lymphoma 13Neoplasms, Plasma Cell 12Multiple Myeloma 12Leukemia, Lymphocytic, Chronic, B-Cell 12Lymphoma, B-Cell, Marginal Zone 10Leukemia, Myeloid, Chronic-Phase 10Neuroblastoma 9Myelodysplastic Syndromes 9Hodgkin Disease 9Congenital Abnormalities 9Leukemia, Myelomonocytic, Chronic 8Leukemia, Myeloid, Accelerated Phase 8Myeloproliferative Disorders 7Central Nervous System Neoplasms 7Blast Crisis 7Waldenstrom Macroglobulinemia 6Primary Myelofibrosis 6Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Polycythemia Vera 5

Interventions

Amifostine 9Radiotherapy 6Cisplatin 5Paclitaxel 4Etoposide 3Cyclophosphamide 3Carboplatin 3sargramostim 1lometrexol 1denileukin diftitox 1Thiotepa 1Taxes 1Silymarin 1Radiation 1Pyridostigmine Bromide 1Phenobarbital 1Peripheral Blood Stem Cell Transplantation 1Mitoxantrone 1Irinotecan 1Ifosfamide 1Idarubicin 1Folic Acid 1Filgrastim 1Fibroblast Growth Factor 7 1Docetaxel 1Dexamethasone 1Cytarabine 1Cyclosporine 1Bleomycin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Drug-Related Side Effects and Adverse Reactions × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00003068 2013-01-31

High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
Breast

Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡